ID   CYC2_CAMAC              Reviewed;         390 AA.
AC   A0A1C9CX66;
DT   23-MAY-2018, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2016, sequence version 1.
DT   22-APR-2020, entry version 10.
DE   RecName: Full=(S)-8-oxocitronellyl enol synthase CYC2 {ECO:0000305};
DE            EC=1.3.1.122 {ECO:0000269|PubMed:27432874};
DE   AltName: Full=Cyclase 2 {ECO:0000303|PubMed:27432874};
DE   AltName: Full=Iridoid synthase {ECO:0000305};
DE            Short=ISY {ECO:0000305};
GN   Name=CYC2 {ECO:0000303|PubMed:27432874};
OS   Camptotheca acuminata (Happy tree).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   asterids; Cornales; Nyssaceae; Camptotheca.
OX   NCBI_TaxID=16922;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=27432874; DOI=10.1105/tpc.16.00193;
RA   Sadre R., Magallanes-Lundback M., Pradhan S., Salim V., Mesberg A.,
RA   Jones A.D., DellaPenna D.;
RT   "Metabolite diversity in alkaloid biosynthesis: a multilane (diastereomer)
RT   highway for camptothecin synthesis in Camptotheca acuminata.";
RL   Plant Cell 28:1926-1944(2016).
CC   -!- FUNCTION: Iridoid synthase that catalyzes the first step in generation
CC       of the iridoid ring scaffold using the linear monoterpene (6E)-8-
CC       oxogeranial as substrate. Iridoids comprise a large family of
CC       distinctive bicyclic monoterpenes that possess a wide range of
CC       pharmacological activities, including anticancer, anti-inflammatory,
CC       antifungal and antibacterial activities. {ECO:0000250|UniProtKB:K7WDL7,
CC       ECO:0000269|PubMed:27432874}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-8-oxocitronellyl enol + NADP(+) = (6E)-8-oxogeranial +
CC         H(+) + NADPH; Xref=Rhea:RHEA:62592, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:64239,
CC         ChEBI:CHEBI:144481; EC=1.3.1.122;
CC         Evidence={ECO:0000250|UniProtKB:K7WDL7, ECO:0000269|PubMed:27432874};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:62594;
CC         Evidence={ECO:0000250|UniProtKB:K7WDL7, ECO:0000269|PubMed:27432874};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-8-oxocitronellyl enol + NAD(+) = (6E)-8-oxogeranial + H(+)
CC         + NADH; Xref=Rhea:RHEA:62596, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:64239, ChEBI:CHEBI:144481;
CC         EC=1.3.1.122; Evidence={ECO:0000250|UniProtKB:K7WDL7,
CC         ECO:0000269|PubMed:27432874};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:62598;
CC         Evidence={ECO:0000250|UniProtKB:K7WDL7, ECO:0000269|PubMed:27432874};
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. Highly divergent. {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to catalyze the entire reaction from
CC       (6E)-8-oxogeranial to nepetalactol including a cyclase step, but new
CC       results have shown that the cyclase is a different enzyme and this
CC       enzyme exclusively catalyzes a reduction step.
CC       {ECO:0000250|UniProtKB:K7WDL7}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU842379; AON76723.1; -; mRNA.
DR   SMR; A0A1C9CX66; -.
DR   GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IDA:UniProtKB.
DR   GO; GO:0043693; P:monoterpene biosynthetic process; IDA:UniProtKB.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   NADP; Oxidoreductase.
FT   CHAIN           1..390
FT                   /note="(S)-8-oxocitronellyl enol synthase CYC2"
FT                   /id="PRO_0000444194"
FT   NP_BIND         35..37
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
FT   NP_BIND         63..64
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
FT   NP_BIND         81..82
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
FT   NP_BIND         105..106
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
FT   NP_BIND         213..215
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
FT   ACT_SITE        147
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
FT   ACT_SITE        179
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
FT   BINDING         143
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
FT   BINDING         147
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
FT   BINDING         179
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
FT   BINDING         179
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:K7WDL7"
SQ   SEQUENCE   390 AA;  43785 MW;  293B7068B32E441E CRC64;
     MSWWWAGAIG AARKKFEEDD APRDCQSVAL IIGVTGIVGN SLAEILPISD TPGGPWKVYG
     VARRPRPAWN ADHPVEYIQC DISDASDTHT KLSPLTDVTH IFWVTWANRP TESECCELNG
     TMLRNVLNAL IPKAANLHHI CLQTGHKHYI GPFEAFGKIK PHEPPFTEDM PRLNAPNFYY
     TLEDMLVEAS EKKAGLNWSV HRPAVIFGFS PFSMMNIIGT LCVYAAICKH ENTPLKFPGT
     KAAWNCYSVA SDADLIAEHQ IWAAVDPYAK NEAFNCSNGD LFKWKHLWKV LAEQFGVEYA
     EFDESEKPTS LVERMKDKGP VWEEIVRENG LHTTKLEGVA TWWFADVILG GECLLDSMNK
     SKEHGYLGFR NTKNSLISVI DKMKAHKIVP
//
